CD19 Antibody MOR208 in Relapsed or Refractory B-Cell NHL CD19 Antibody MOR208 in Relapsed or Refractory B-Cell NHL

MOR208, an Fc-engineered, humanized, CD19 antibody, shows promise in rituximab-refractory B-cell NHL and follicular lymphoma.Annals of Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news